<![CDATA[Takeda Pharmaceutical Company Limited & Neurocrine Biosciences, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=35343>Tue, 14 Apr 2026 16:46:57 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders]]>https://www.newswire.co.kr/newsRead.php?no=906578Thu, 18 Jun 2020 16:40:00 +0900<![CDATA[다케다와 뉴로크라인 바이오사이언스, 정신의학 분야 질병 치료제 개발 및 상업화 위해 전략적 협력관계 맺어]]>https://www.newswire.co.kr/newsRead.php?no=906579Thu, 18 Jun 2020 16:40:00 +0900